Insulin Glargine in Type 2 Diabetes Mellitus

NCT00311818 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: Insulin glargine

Sponsor

Sanofi